The program is called the Medicare GLP-1 Bridge
doi: 10.1016/0165-1838(83)90134-0 [DOI] [PubMed] [Google Scholar] 69.Broide E, Bloch O, Ben-Yehudah G, et al
Weight Regain: A Difficult Challenge A significant concern for many patients discontinuing GLP-1 therapy is the potential for weight regain
As surprising as it sounds, emerging evidence suggests a meaningful connection
If the response is weaker than expected, your clinician may review the dose, timing, peptide choice, lifestyle factors, labs, or other health issues that could be slowing progress
Leanne is a professional science writer who specializes in human health and enjoys writing about all things related to the gut microbiome.